These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1644096)

  • 21. Effects of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle.
    Pierno S; De Luca A; Liantonio A; Camerino C; Conte Camerino D
    Eur J Pharmacol; 1999 Jan; 364(1):43-8. PubMed ID: 9920183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study.
    Nakahara K; Kuriyama M; Sonoda Y; Yoshidome H; Nakagawa H; Fujiyama J; Higuchi I; Osame M
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):99-106. PubMed ID: 9772205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy].
    Blaison G; Weber JC; Sachs D; Korganow AS; Martin T; Kretz JG; Pasquali JL
    Rev Med Interne; 1992; 13(1):61-3. PubMed ID: 1410877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.
    Pierno S; De Luca A; Tricarico D; Roselli A; Natuzzi F; Ferrannini E; Laico M; Camerino DC
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1490-6. PubMed ID: 8531120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ; Kantola T; Kivistö KT
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.
    Morris MJ; Gilbert JD; Hsieh JY; Matuszewski BK; Ramjit HG; Bayne WF
    Biol Mass Spectrom; 1993 Jan; 22(1):1-8. PubMed ID: 8431499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
    Regazzi MB; Iacona I; Campana C; Gavazzi A; Viganò M; Perani G
    Transplant Proc; 1994 Oct; 26(5):2644-5. PubMed ID: 7940825
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin.
    Pan HY; Triscari J; DeVault AR; Smith SA; Wang-Iverson D; Swanson BN; Willard DA
    Br J Clin Pharmacol; 1991 Jun; 31(6):665-70. PubMed ID: 1907839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Simvastatin].
    Burgmer U; Mohr K
    Dtsch Med Wochenschr; 1996 Jun; 121(23):769-70. PubMed ID: 8646995
    [No Abstract]   [Full Text] [Related]  

  • 31. Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors.
    Krasovec M; Elsner P; Burg G
    Dermatology; 1993; 186(4):248-52. PubMed ID: 8513188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors.
    Nakahara K; Yada T; Kuriyama M; Osame M
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1579-85. PubMed ID: 8060342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
    De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH
    Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat.
    Koga T; Fukuda K; Shimada Y; Fukami M; Koike H; Tsujita Y
    Eur J Biochem; 1992 Oct; 209(1):315-9. PubMed ID: 1396707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of pravastatin and cyclosporin in transplant patients.
    Christians U
    Clin Pharmacokinet; 1997 Feb; 32(2):173-4. PubMed ID: 9068930
    [No Abstract]   [Full Text] [Related]  

  • 37. Regioselectivity and stereoselectivity in the metabolism of HMG-CoA reductase inhibitors.
    Vyas KP; Kari PH; Pitzenberger SM
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1155-62. PubMed ID: 2306236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM; Thompson GR
    Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.
    Vickers S; Duncan CA; Chen IW; Rosegay A; Duggan DE
    Drug Metab Dispos; 1990; 18(2):138-45. PubMed ID: 1971563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
    Aronson JK; Ng LL
    Q J Med; 1990 Feb; 74(274):111-5. PubMed ID: 2111916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.